These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21294655)

  • 1. Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species.
    Frey T; Antonetti DA
    Antioxid Redox Signal; 2011 Sep; 15(5):1271-84. PubMed ID: 21294655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new view of diabetic retinopathy: a neurodegenerative disease of the eye.
    Barber AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):283-90. PubMed ID: 12657367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of vascular permeability in diabetic retinopathy.
    Antonetti DA; Lieth E; Barber AJ; Gardner TW
    Semin Ophthalmol; 1999 Dec; 14(4):240-8. PubMed ID: 10758225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking CXCR3 with AMG487 ameliorates the blood-retinal barrier disruption in diabetic mice through anti-oxidative.
    Wang H; Li J; Zhong P; Wang S; Zhang L; Yang R; Wu D; Chen M; Ji A; Li Y; Wang J
    Life Sci; 2019 Jul; 228():198-207. PubMed ID: 31039363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy.
    Xu J; Chen LJ; Yu J; Wang HJ; Zhang F; Liu Q; Wu J
    Cell Physiol Biochem; 2018; 48(2):705-717. PubMed ID: 30025404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid regulation of endothelial cell tight junction gene expression: novel treatments for diabetic retinopathy.
    Felinski EA; Antonetti DA
    Curr Eye Res; 2005 Nov; 30(11):949-57. PubMed ID: 16282129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
    Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.
    Li L; Renier G
    Metabolism; 2006 Nov; 55(11):1516-23. PubMed ID: 17046555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
    Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW
    Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective factors in diabetic retinopathy: focus on blood-retinal barrier.
    Zhang C; Wang H; Nie J; Wang F
    Discov Med; 2014 Sep; 18(98):105-12. PubMed ID: 25227751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of oxidative stress after retinal laser photocoagulation in nonproliferative diabetic retinopathy.
    Galetović D; Bojić L; Bućan K; Karlica D; Lesin M; Znaor L
    Coll Antropol; 2011 Sep; 35(3):835-40. PubMed ID: 22053564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes.
    Navaratna D; McGuire PG; Menicucci G; Das A
    Diabetes; 2007 Sep; 56(9):2380-7. PubMed ID: 17536065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI retinovascular studies in humans: research in patients with diabetes.
    Trick GL; Edwards PA; Desai U; Morton PE; Latif Z; Berkowitz BA
    NMR Biomed; 2008 Nov; 21(9):1003-12. PubMed ID: 18821575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy.
    Kim JH; Kim JH; Yu YS; Min BH; Kim KW
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1659-65. PubMed ID: 19875648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of tight junctions and loss of barrier function in pathophysiology.
    Harhaj NS; Antonetti DA
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1206-37. PubMed ID: 15109567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in biochemical mechanisms of diabetic retinopathy.
    Giusti C; Gargiulo P
    Eur Rev Med Pharmacol Sci; 2007; 11(3):155-63. PubMed ID: 17970231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occipital blood-brain barrier permeability is an independent predictor of visual outcome in type 2 diabetes, irrespective of the retinal barrier: A longitudinal study.
    Abuhaiba SI; Cordeiro M; Amorim A; Cruz Â; Quendera B; Ferreira C; Ribeiro L; Bernardes R; Castelo-Branco M
    J Neuroendocrinol; 2018 Jan; 30(1):. PubMed ID: 29247551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.